MedDataX Logo

Study of LED Phototherapy for Musculoligamentous Lesions

NCT ID: NCT00382941

Last Updated: 2008-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether LED phototherapy using combined red and near infrared light (approved: Ministry of Health of Russian Federation No. 29/06070997/1080-00, EUROCAT Certificate No. CP033321-IV) is effective in the treatment of musculoligamentous lesions in physiotherapy practice

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tendinopathy Sprains and Strains Muscle Spasm Epicondylitis Fasciitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Red and near infrared LED phototherapy device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of acute or chronic musculoligamentous lesion
* Must be able to understand instructions and fill in auto administered questionnaires
* Informed consent

Exclusion Criteria

* Use of oral corticosteroids or corticosteroid injections
* Systemic diseases
* General contraindications for phototherapy
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hermano Miguel Foundation

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sergiy Voznesenskyy, PhD, BPT

Role: PRINCIPAL_INVESTIGATOR

Hermano Miguel Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CAID, Hermano Miguel Foundation

Quito, Pichincha, Ecuador

Site Status

Health Service, UDV Quito Centro Occidente, National Police of Ecuador

Quito, Pichincha, Ecuador

Site Status

Rehabilitation Department, A.B.E.I. Foundation

Quito, Pichincha, Ecuador

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ecuador

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FT-01-05-05

Identifier Type: -

Identifier Source: org_study_id